MusclePharm Names PondelWilkinson as Investor Relations Counsel
December 31 2013 - 8:30AM
Marketwired
MusclePharm Names PondelWilkinson as Investor Relations Counsel
DENVER, CO--(Marketwired - Dec 31, 2013) - MusclePharm
Corporation (OTCQB: MSLP), a leading international, award-winning
sports nutrition company, today announced that it has retained
PondelWilkinson Inc. as investor relations counsel.
The firm will serve as liaison for MusclePharm to the investment
community, as well as provide counsel for strategic communications
as MusclePharm embarks on its next stage of growth and
development.
"The engagement of PondelWilkinson represents a timely step for
MusclePharm, as we continue to build our company, forge new
relationships with shareholders and the broader investment
community, and look toward listing our shares on a senior
exchange," said Brad Pyatt, MusclePharm's president and
CEO. "Our decision was based on the firm's expertise in the
consumer sector, as well as its experience over many years
representing high profile growth companies."
"We are delighted to join forces at this important stage in the
company's growth, helping to build further brand awareness in the
corporate and investor communities for MusclePharm's distinctive
leadership niche in the sports nutrition sector," said Roger
Pondel, CEO of PondelWilkinson.
About PondelWilkinson PondelWilkinson Inc., founded in 1968,
provides investor relations and strategic public relations counsel
to publicly traded, pre-public and privately owned companies in
various industries, as well as marketing communications support for
professional and financial services firms. View PondelWilkinson's
website at www.pondel.com, and its blog at
www.pwinsight.com.
About MusclePharm MusclePharm® is a leading international,
award-winning sports nutrition company offering vitamins and
nutritional supplements which are available in more than 110
countries and available in 35,000+ retail outlets, including
Costco, Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC,
Vitamin Shoppe and Vitamin World. The company's brands are
MusclePharm®, Arnold Schwarzenegger™ Series, and FitMiss™. The
comprehensive lines of clinically-proven, safe and effective
nutritional supplements are developed through a six-stage research
process that utilizes the expertise of leading nutritional
scientists, doctors and universities. For more information, visit
www.musclepharmcorp.com. Follow the company at
http://www.facebook.com/MusclePharm and
www.Twitter.com/MusclePharm.
Forward-Looking Statements This release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities and Exchange
Act of 1934, as amended. Statements that are not a description of
historical facts constitute forward-looking statements and may
often, but not always, be identified by the use of such words as
"expects", "anticipates", "intends", "estimates", "plans",
"potential", "possible", "probable", "believes", "seeks", "may",
"will", "should", "could" or the negative of such terms or other
similar expressions. Actual results may differ materially from
those set forth in this release due to the risks and uncertainties
inherent in the company's business. More detailed information about
the company and the risk factors that may affect the realization of
forward-looking statements is set forth in the company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2012,
the company's Quarter Reports on Form 10-Q and other filings
submitted by the company to the SEC, copies of which may be
obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
For more information, contact: Matt Sheldon/Evan Pondel
PondelWilkinson Inc. (310) 279-5980 Email Contact
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2024 to May 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From May 2023 to May 2024